@Jdmoney the P2 is not only breast cancer it’s an all comers trials. Haven’t seen other biotechs go ‘all-in’ by starting a basket trial, either crazy or confident (your choice). Bisantrene could be like Bruce Lee’s 1-inch punch to cancer and cardiotoxicity. Looking forward to trials kicking off H2 - 2024!
@Jdmoney the P2 is not only breast cancer it’s an all comers...
-
- There are more pages in this discussion • 206 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
0.050(3.33%) |
Mkt cap ! $264.0M | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.55 | $1.49 | $86.32K | 57.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4520 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 2259 | 1 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |